Comparative gene expression analysis in the liver, kidney and blood vessels during renal injury after repeated exposure to tacrolimus in Sprague-Dawley rats

详细信息    查看全文

• 作者：Sun Mi Hwang ; Se-Myo Park ; Ji-Seong Jeong ; Kyoung-Sik Moon ; Yong-Bum Kim&#8230
• 关键词：Tacrolimus ; Multiple organs interaction ; Kidney toxicity ; Nephrotoxicity ; Liver ; Blood vessel ; Gene expression profiling
• 刊名：BioChip Journal
• 出版年：2015
• 出版时间：September 2015
• 年：2015
• 卷：9
• 期：3
• 页码：202-214
• 全文大小：1,225 KB
• 参考文献：1.Aperia, A., Ibarra, F., Svensson, L.B., Klee, C. & Greengard, P. Calcineurin mediates alpha-adrenergic stimulation of Na+, K(+)-ATPase activity in renal tubule cells. Proc. Natl. Acad. Sci. USA. 89, 7394鈥?397 (1992).CrossRef
  2.Starzl, T.E. et al., FK 506 for liver, kidney, and pancreas transplantation. Lance. 2, 1000鈥?004 (1989).CrossRef
  3.Asai, A. et al., High level calcineurin activity predisposes neuronal cells to apoptosis. J. Biol. Chem. 274, 34450鈥?4458 (1999).CrossRef
  4.Cal貌, L.A. & Davis, P.A. NADPH oxidase subunits (NOX-1, p22phox, Rac-1) and tacrolimus-induced nephrotoxicity in a rat renal transplant model. Nephrol. Dial. Transplant. 22, 2402 (2007).CrossRef
  5.Sklar, E.M. Post-transplant neurotoxicity: what role do calcineurin inhibitors actually play? Am. J. Neuroradiol. 27, 1602鈥?603 (2006).
  6.Takeda, Y., Miyamori, I., Furukawa, K., Inaba, S. & Mabuchi, H. Mechanisms of FK 506-induced hypertension in the rat. Hypertensio. 33, 130鈥?36 (1999).CrossRef
  7.Wang, J. et al. Molecular mechanisms of FK506-induced hypertension in solid organ transplantation patients. Chin. Med. J. (Engl). 127, 3645鈥?650 (2014).
  8.Jin, L. et al. Dipeptidyl peptidase IV inhibitor MK-0626 attenuates pancreatic islet injury in tacrolimus-induced diabetic rats. PLoS One 9, e100798 (2014).CrossRef
  9.Rodriguez-Rodriguez, A.E. et al. The higher diabetogenic risk of tacrolimus depends on pre-existing insulin resistance. A study in obese and lean Zucker rats. Am. J. Transplant. 13, 1665鈥?675 (2013).CrossRef
  10.Hern谩ndez-Fisac, I. et al. Tacrolimus-induced diabetes in rats courses with suppressed insulin gene expression in pancreatic islets. Am. J. Transplant. 7, 2455鈥?462 (2007).CrossRef
  11.Ha, H. et al. Artemisia capillaris inhibits atopic dermatitis-like skin lesions in Dermatophagoides farinae-sensitized Nc/Nga mice. BMC Complement. Altern. Med. 14, 100 (2014).CrossRef
  12.Narabayashi, K. et al. Oral tacrolimus for megacolon in patients with severe ulcerative colitis. Intern. Med. 53, 1755鈥?758 (2014).CrossRef
  13.Rigby, A.L., Plit, M. & Glanville, A.R. Tacrolimus rescue therapy for severe respiratory failure in the anti-synthetase syndrome. Respirol. Case Rep. 2, 70鈥?2 (2014).CrossRef
  14.Que, J. et al. Tacrolimus reduces scar formation and promotes sciatic nerve regeneration. Neural. Regen. Res. 7, 2500鈥?506 (2012).
  15.Storogenko, M., Pech-Amsellem, M.A., Kerdine, S., Rousselet, F. & Pallardy, M. Cyclosporin-A inhibits human endothelial cells proliferation through interleukin-6-dependent mechanisms. Life Sci. 60, 1487鈥?496 (1997).CrossRef
  16.Sharpe, R.J., Arndt, K.A., Bauer, S.I. & Maione, T.E. Cyclosporine inhibits basic fibroblast growth factordriven proliferation of human endothelial cells and keratinocytes. Arch. Dermatol. 125, 1359鈥?362 (1989).CrossRef
  17.Araujo, L.P. et al. Interaction of the anti-inflammatory annexin A1 protein and tacrolimus immunosuppressant in the renal function of rats. Am. J. Nephrol. 31, 527鈥?33 (2010).CrossRef
  18.Nielsen, F.T., Leyssac, P.P., Kemp, E., Starklint, H. & Dieperink, H. Nephrotoxicity of FK-506 in the rat. Studies on glomerular and tubular function, and on the relationship between efficacy and toxicity. Nephrol. Dial. Transplant. 10, 334鈥?40 (1995).
  19.Aicher, L. et al. Decrease in kidney calbindin-D 28kDa as a possible mechanism mediating cyclosporine Aand FK-506-induced calciuria and tubular mineralization. Biochem. Pharmacol. 53, 723鈥?31 (1997).CrossRef
  20.Vafadari, R., Kraaijeveld, R., Weimar, W. & Baan, C.C. Tacrolimus inhibits NF-魏B activation in peripheral human T cells. PLoS One 8, e60784 (2013).CrossRef
  21.Steffan, N.M. et al. Regulation of IkB alpha phosphorylation by PKC- and Ca(2+)-dependent signal transduction pathways. J. Immunol. 155, 4685鈥?691 (1995).
  22.Bai, L. et al. Low- but not high-dose FK506 treatment confers atheroprotection due to alternative macrophage activation and unaffected cholesterol levels. Thromb. Haemost. 104, 143鈥?50 (2010).CrossRef
  23.Venkiteswaran, K., Sgoutas, D.S., Santanam, N. & Neylan, J.F. Tacrolimus, cyclosporine and plasma lipoproteins in renal transplant recipients. Transpl. Int. 14, 405鈥?10 (2001).CrossRef
  24.Marchetti, P. & Navalesi, R. The metabolic effects of cyclosporin and tacrolimus. J. Endocrinol. Invest. 23, 482鈥?90 (2000).CrossRef
  25.Khanna, A.K. & Pieper, G.M. NADPH oxidase subunits (NOX-1, p22phox, Rac-1) and tacrolimus-induced nephrotoxicity in a rat renal transplant model. Nephrol. Dial. Transplant. 22, 376鈥?85 (2007).CrossRef
  26.O臒眉tmen, B., Tu臒lular, S., Cakala臒ao臒lu, F., Ozener, C. & Ako臒lu, E. Transforming growth factor-beta1, vascular endothelial growth factor, and bone morphogenic protein-7 expression in tacrolimus-induced nephrotoxicity in rats. Transplant. Proc. 38, 487鈥?89 (2006).CrossRef
  27.Karlsson, M., Tornqvist, H. & Holm, C. Expression, purification, and characterization of histidine-tagged mouse monoglyceride lipase from baculovirus-infected insect cells. Protein Expr. Purif. 18, 286鈥?92 (2000).CrossRef
  28.Sugiura, T., Kishimoto, S., Oka, S. & Gokoh, M. Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. Prog. Lipid Res. 45, 405鈥?46 (2006).CrossRef
  29.Taschler, U. et al. Monoglyceride lipase deficiency in mice impairs lipolysis and attenuates diet-induced insulin resistance. J. Biol. Chem. 286, 17467鈥?7477 (2011).CrossRef
  30.Yamada, R. & Ymamoto, K. Recent findings on genes associated with inflammatory disease. Mutat. Res. 573, 136鈥?51 (2005).CrossRef
  31.Clarke, E. et al. Functional characterization of the atopy-associated gene PHF11. J. Allergy Clin. Immunol. 121, 1148鈥?154 (2008).CrossRef
  32.Hodge-Dufour, J. et al. Inhibition of interferon gamma induced interleukin 12 production: a potential mechanism for the anti-inflammatory activities of tumor necrosis factor. Proc. Natl. Acad. Sci. USA. 95, 13806鈥?3811 (1998).CrossRef
  33.Viollet, B. et al. Review. AMPK inhibition in health and disease. Crit. Rev. Biochem. Mol. Biol. 45, 276鈥?95 (2010).CrossRef
  34.Sag, D., Carling, D., Stout, R.D. & Suttles, J. Adenosine 5鈥?monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J. Immunol. 181, 8633鈥?641 (2008).CrossRef
  35.Jeong, H.W. et al. Berberine suppresses proinflammatory responses through AMPK activation in macrophages. Am. J. Physiol. Endocrinol. Metab. 296, E955鈥揈964 (2009).CrossRef
  36.Trinchieri, G. Interleukin-12 and interferon-gamma. Do they always go together? Am. J. Pathol. 147, 1534鈥?538 (1995).
  37.Livak, K.J. & Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Method. 25, 402鈥?08 (2001).CrossRef
  
• 作者单位：Sun Mi Hwang (1)
  Se-Myo Park (1)
  Ji-Seong Jeong (1)
  Kyoung-Sik Moon (1)
  Yong-Bum Kim (1)
  Seokjoo Yoon (1) (2)
  Jung-Hwa Oh (1) (2)
  
  1. Korea Institute of Toxicology (KIT), 141 Gajeong-ro, Yuseong-gu, Daejeon, 305-343, Korea
  2. Department of Human and Environmental Toxicology, University of Science & Technology, Daejeon, 305-350, Korea
  
• 刊物类别：Chemistry and Materials Science
• 刊物主题：Chemistry
  Biotechnology
  
• 出版者：The Korean BioChip Society, in co-publication with Springer Verlag GmbH
• ISSN：2092-7843

文摘

To elucidate the molecular mechanisms associated with renal injury based on multi-organ interactions, we simultaneously examined the changes in expression profiles of the liver, kidneys, and blood vessels after treatment with the nephrotoxic drug tacrolimus. Sprague-Dawley rats were treated daily with tacrolimus and sacrificed 28 d after oral administration. Serum biochemistry analysis of the major injury markers was performed. Histopathological characteristics were also observed. Total RNA was extracted from the liver, kidneys, and blood vessels from the thoracic aorta, followed by microarray analysis. Differentially expressed genes were selected based on 1.5-fold changes and statistical significance (P<0.05). The effects of three dosages of tacrolimus on transcription levels were analyzed within and among the three organs. Gene functions, as well as the biological and toxicological functions of the differentially regulated genes, were analyzed using Ingenuity Pathways Analysis (IPA). IPA identified genes involved in metabolic activation, including lipid metabolism, renal tubule injury, and cell proliferation in tacrolimus-treated livers, kidneys, and blood vessels, respectively. In response to tacrolimus treatment, genes related to lipid metabolic responses were regulated in the three organs similarly. Genes associated with inflammatory response were regulated in the liver and kidneys similarly. Based on the results from this study, we suggest the molecular pathways involved in the response to tacrolimus in multiple organs. We also provide information about candidate genes, to evaluate the toxicity induced by tacrolimus. These results might be helpful to elucidate the underlying mechanisms of nephrotoxicity by interaction among multiple organs. Keywords Tacrolimus Multiple organs interaction Kidney toxicity Nephrotoxicity Liver Blood vessel Gene expression profiling